-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Fresh Tracks Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Fresh Tracks Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2023 was -$1.24M, a 72.7% increase year-over-year.
- Fresh Tracks Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2023 was -$5.69M, a 73% increase year-over-year.
- Fresh Tracks Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$5.69M, a 73% increase from 2022.
- Fresh Tracks Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$21.1M, a 46.5% increase from 2021.
- Fresh Tracks Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$39.5M, a 88.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)